首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Alpha interferon improves survival in patients with metastatic renal carcinoma - Updated results of an MRC randomised controlled trial.
被引:0
|
作者
:
Oliver, RTD
论文数:
0
引用数:
0
h-index:
0
机构:
MRC, Clin Trials Unit, Canc Div, Cambridge CB2 2BW, England
MRC, Clin Trials Unit, Canc Div, Cambridge CB2 2BW, England
Oliver, RTD
[
1
]
机构
:
[1]
MRC, Clin Trials Unit, Canc Div, Cambridge CB2 2BW, England
来源
:
BRITISH JOURNAL OF CANCER
|
1999年
/ 80卷
关键词
:
D O I
:
暂无
中图分类号
:
R73 [肿瘤学];
学科分类号
:
100214 ;
摘要
:
P161
引用
收藏
页码:69 / 69
页数:1
相关论文
共 50 条
[1]
Interferon-α and survival in metastatic renal carcinoma:: early results of a randomised controlled trial
Ritchie, A
论文数:
0
引用数:
0
h-index:
0
机构:
MRC, Canc Trials Off, RE01 Trial, Cambridge CB2 2BW, England
Ritchie, A
Griffiths, G
论文数:
0
引用数:
0
h-index:
0
机构:
MRC, Canc Trials Off, RE01 Trial, Cambridge CB2 2BW, England
Griffiths, G
Parmar, M
论文数:
0
引用数:
0
h-index:
0
机构:
MRC, Canc Trials Off, RE01 Trial, Cambridge CB2 2BW, England
Parmar, M
Fossa, SD
论文数:
0
引用数:
0
h-index:
0
机构:
MRC, Canc Trials Off, RE01 Trial, Cambridge CB2 2BW, England
Fossa, SD
Selby, PJ
论文数:
0
引用数:
0
h-index:
0
机构:
MRC, Canc Trials Off, RE01 Trial, Cambridge CB2 2BW, England
Selby, PJ
Cornbleet, MA
论文数:
0
引用数:
0
h-index:
0
机构:
MRC, Canc Trials Off, RE01 Trial, Cambridge CB2 2BW, England
Cornbleet, MA
Sibley, G
论文数:
0
引用数:
0
h-index:
0
机构:
MRC, Canc Trials Off, RE01 Trial, Cambridge CB2 2BW, England
Sibley, G
Mead, GM
论文数:
0
引用数:
0
h-index:
0
机构:
MRC, Canc Trials Off, RE01 Trial, Cambridge CB2 2BW, England
Mead, GM
Kaye, S
论文数:
0
引用数:
0
h-index:
0
机构:
MRC, Canc Trials Off, RE01 Trial, Cambridge CB2 2BW, England
Kaye, S
Owen, JR
论文数:
0
引用数:
0
h-index:
0
机构:
MRC, Canc Trials Off, RE01 Trial, Cambridge CB2 2BW, England
Owen, JR
Oliver, RTD
论文数:
0
引用数:
0
h-index:
0
机构:
MRC, Canc Trials Off, RE01 Trial, Cambridge CB2 2BW, England
Oliver, RTD
Smith, PH
论文数:
0
引用数:
0
h-index:
0
机构:
MRC, Canc Trials Off, RE01 Trial, Cambridge CB2 2BW, England
Smith, PH
Whelan, P
论文数:
0
引用数:
0
h-index:
0
机构:
MRC, Canc Trials Off, RE01 Trial, Cambridge CB2 2BW, England
Whelan, P
Cook, PA
论文数:
0
引用数:
0
h-index:
0
机构:
MRC, Canc Trials Off, RE01 Trial, Cambridge CB2 2BW, England
Cook, PA
Fayers, PM
论文数:
0
引用数:
0
h-index:
0
机构:
MRC, Canc Trials Off, RE01 Trial, Cambridge CB2 2BW, England
Fayers, PM
Cook, P
论文数:
0
引用数:
0
h-index:
0
机构:
MRC, Canc Trials Off, RE01 Trial, Cambridge CB2 2BW, England
Cook, P
Webb, J
论文数:
0
引用数:
0
h-index:
0
机构:
MRC, Canc Trials Off, RE01 Trial, Cambridge CB2 2BW, England
Webb, J
Whitehead, J
论文数:
0
引用数:
0
h-index:
0
机构:
MRC, Canc Trials Off, RE01 Trial, Cambridge CB2 2BW, England
Whitehead, J
Lamont, A
论文数:
0
引用数:
0
h-index:
0
机构:
MRC, Canc Trials Off, RE01 Trial, Cambridge CB2 2BW, England
Lamont, A
LANCET,
1999,
353
(9146):
: 14
-
17
[2]
Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
Motzer, Robert J.
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
Motzer, Robert J.
Hutson, Thomas E.
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
Hutson, Thomas E.
Tomczak, Piotr
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
Tomczak, Piotr
Michaelson, M. Dror
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
Michaelson, M. Dror
Bukowski, Ronald M.
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
Bukowski, Ronald M.
Oudard, Stephane
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
Oudard, Stephane
Negrier, Sylvie
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
Negrier, Sylvie
Szczylik, Cezary
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
Szczylik, Cezary
Pili, Roberto
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
Pili, Roberto
Bjarnason, Georg A.
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
Bjarnason, Georg A.
Garcia-del-Muro, Xavier
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
Garcia-del-Muro, Xavier
Sosman, Jeffrey A.
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
Sosman, Jeffrey A.
Solska, Ewa
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
Solska, Ewa
Wilding, George
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
Wilding, George
Thompson, John A.
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
Thompson, John A.
Kim, Sindy T.
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
Kim, Sindy T.
Chen, Isan
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
Chen, Isan
Huang, Xin
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
Huang, Xin
Figlin, Robert A.
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
Figlin, Robert A.
JOURNAL OF CLINICAL ONCOLOGY,
2009,
27
(22)
: 3584
-
3590
[3]
Bevacizumab plus interferon-alpha versus interferon-alpha monotherapy in patients with metastatic renal cell carcinoma: Results of overall survival for CALGB 90206
Rini, B. I.
论文数:
0
引用数:
0
h-index:
0
机构:
Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
Rini, B. I.
Halabi, S.
论文数:
0
引用数:
0
h-index:
0
机构:
Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
Halabi, S.
Rosenberg, J.
论文数:
0
引用数:
0
h-index:
0
机构:
Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
Rosenberg, J.
Stadler, W. M.
论文数:
0
引用数:
0
h-index:
0
机构:
Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
Stadler, W. M.
Vaena, D. A.
论文数:
0
引用数:
0
h-index:
0
机构:
Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
Vaena, D. A.
Atkins, J. N.
论文数:
0
引用数:
0
h-index:
0
机构:
Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
Atkins, J. N.
Picus, J.
论文数:
0
引用数:
0
h-index:
0
机构:
Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
Picus, J.
Czaykowski, P.
论文数:
0
引用数:
0
h-index:
0
机构:
Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
Czaykowski, P.
Dutcher, J.
论文数:
0
引用数:
0
h-index:
0
机构:
Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
Dutcher, J.
Small, E. J.
论文数:
0
引用数:
0
h-index:
0
机构:
Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
Small, E. J.
JOURNAL OF CLINICAL ONCOLOGY,
2009,
27
(15)
[4]
Bevacizumab plus interferon-alpha versus interferon-alpha monotherapy in patients with metastatic renal cell carcinoma: Results of overall survival for CALGB 90206
Rini, B. I.
论文数:
0
引用数:
0
h-index:
0
机构:
Cleveland Clin Taussig Canc Inst, Cleveland, OH USA
Rini, B. I.
Halabi, S.
论文数:
0
引用数:
0
h-index:
0
机构:
Cleveland Clin Taussig Canc Inst, Cleveland, OH USA
Halabi, S.
Rosenberg, J.
论文数:
0
引用数:
0
h-index:
0
机构:
Cleveland Clin Taussig Canc Inst, Cleveland, OH USA
Rosenberg, J.
Stadler, W. M.
论文数:
0
引用数:
0
h-index:
0
机构:
Cleveland Clin Taussig Canc Inst, Cleveland, OH USA
Stadler, W. M.
Vaena, D. A.
论文数:
0
引用数:
0
h-index:
0
机构:
Cleveland Clin Taussig Canc Inst, Cleveland, OH USA
Vaena, D. A.
Atkins, J. N.
论文数:
0
引用数:
0
h-index:
0
机构:
Cleveland Clin Taussig Canc Inst, Cleveland, OH USA
Atkins, J. N.
Picus, J.
论文数:
0
引用数:
0
h-index:
0
机构:
Cleveland Clin Taussig Canc Inst, Cleveland, OH USA
Picus, J.
Czaykowski, P.
论文数:
0
引用数:
0
h-index:
0
机构:
Cleveland Clin Taussig Canc Inst, Cleveland, OH USA
Czaykowski, P.
Dutcher, J.
论文数:
0
引用数:
0
h-index:
0
机构:
Cleveland Clin Taussig Canc Inst, Cleveland, OH USA
Dutcher, J.
Small, E. J.
论文数:
0
引用数:
0
h-index:
0
机构:
Cleveland Clin Taussig Canc Inst, Cleveland, OH USA
Small, E. J.
JOURNAL OF CLINICAL ONCOLOGY,
2009,
27
(18)
[5]
Combined interferon alpha with levamisole in patients with metastatic renal cell carcinoma
Aksoy H.
论文数:
0
引用数:
0
h-index:
0
机构:
Ümitköy girişi Melis Sitesi, Çayyolu, Ankara 06530
Ümitköy girişi Melis Sitesi, Çayyolu, Ankara 06530
Aksoy H.
Baltaci S.
论文数:
0
引用数:
0
h-index:
0
机构:
Department of Urology, Ankara University, School of Medicine, Ankara
Ümitköy girişi Melis Sitesi, Çayyolu, Ankara 06530
Baltaci S.
Türkölmez K.
论文数:
0
引用数:
0
h-index:
0
机构:
Department of Urology, Ankara University, School of Medicine, Ankara
Ümitköy girişi Melis Sitesi, Çayyolu, Ankara 06530
Türkölmez K.
Seçkiner I.
论文数:
0
引用数:
0
h-index:
0
机构:
Department of Urology, Ankara University, School of Medicine, Ankara
Ümitköy girişi Melis Sitesi, Çayyolu, Ankara 06530
Seçkiner I.
Bedük Y.
论文数:
0
引用数:
0
h-index:
0
机构:
Department of Urology, Ankara University, School of Medicine, Ankara
Ümitköy girişi Melis Sitesi, Çayyolu, Ankara 06530
Bedük Y.
International Urology and Nephrology,
2001,
33
(3)
: 457
-
459
[6]
Do cytokines improve survival in patients with metastatic renal cell carcinoma (MRCC) of intermediate prognosis? Results of the prospective randomized PERCY Quattro trial.
Negrier, S
论文数:
0
引用数:
0
h-index:
0
机构:
French Immunotherapy Inergroup, Lyon, France
Negrier, S
Perol, D
论文数:
0
引用数:
0
h-index:
0
机构:
French Immunotherapy Inergroup, Lyon, France
Perol, D
Ravaud, A
论文数:
0
引用数:
0
h-index:
0
机构:
French Immunotherapy Inergroup, Lyon, France
Ravaud, A
Chevreau, C
论文数:
0
引用数:
0
h-index:
0
机构:
French Immunotherapy Inergroup, Lyon, France
Chevreau, C
Bay, JO
论文数:
0
引用数:
0
h-index:
0
机构:
French Immunotherapy Inergroup, Lyon, France
Bay, JO
Delva, R
论文数:
0
引用数:
0
h-index:
0
机构:
French Immunotherapy Inergroup, Lyon, France
Delva, R
Sevin, E
论文数:
0
引用数:
0
h-index:
0
机构:
French Immunotherapy Inergroup, Lyon, France
Sevin, E
Caty, A
论文数:
0
引用数:
0
h-index:
0
机构:
French Immunotherapy Inergroup, Lyon, France
Caty, A
Tubiana-Mathieu, N
论文数:
0
引用数:
0
h-index:
0
机构:
French Immunotherapy Inergroup, Lyon, France
Tubiana-Mathieu, N
Escudier, B
论文数:
0
引用数:
0
h-index:
0
机构:
French Immunotherapy Inergroup, Lyon, France
Escudier, B
JOURNAL OF CLINICAL ONCOLOGY,
2005,
23
(16)
: 1093S
-
1093S
[7]
PROGNOSTIC FACTORS AND SURVIVAL IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA TREATED WITH CHEMOTHERAPY OR INTERFERON-ALPHA
FOSSA, SD
论文数:
0
引用数:
0
h-index:
0
机构:
INST GUSTAVE ROUSSY,DEPT MED,VILLEJUIF,FRANCE
FOSSA, SD
KRAMAR, A
论文数:
0
引用数:
0
h-index:
0
机构:
INST GUSTAVE ROUSSY,DEPT MED,VILLEJUIF,FRANCE
KRAMAR, A
DROZ, JP
论文数:
0
引用数:
0
h-index:
0
机构:
INST GUSTAVE ROUSSY,DEPT MED,VILLEJUIF,FRANCE
DROZ, JP
EUROPEAN JOURNAL OF CANCER,
1994,
30A
(09)
: 1310
-
1314
[8]
Can exercise influence survival following breast cancer: Results from a randomised, controlled trial.
Hayes, Sandra Christine
论文数:
0
引用数:
0
h-index:
0
Hayes, Sandra Christine
Steele, Megan
论文数:
0
引用数:
0
h-index:
0
Steele, Megan
Spence, Rosa
论文数:
0
引用数:
0
h-index:
0
Spence, Rosa
Pyke, Christopher
论文数:
0
引用数:
0
h-index:
0
Pyke, Christopher
Saunders, Christobel
论文数:
0
引用数:
0
h-index:
0
Saunders, Christobel
Bashford, John
论文数:
0
引用数:
0
h-index:
0
Bashford, John
Eakin, Elizabeth
论文数:
0
引用数:
0
h-index:
0
Eakin, Elizabeth
JOURNAL OF CLINICAL ONCOLOGY,
2017,
35
[9]
Subcutaneous administration of interferon alpha and gamma in patients with metastatic renal cell carcinoma
Koga, S
论文数:
0
引用数:
0
h-index:
0
机构:
Nagasaki Univ, Sch Med, Dept Urol, Nagasaki 8528501, Japan
Nagasaki Univ, Sch Med, Dept Urol, Nagasaki 8528501, Japan
Koga, S
Nishikido, M
论文数:
0
引用数:
0
h-index:
0
机构:
Nagasaki Univ, Sch Med, Dept Urol, Nagasaki 8528501, Japan
Nagasaki Univ, Sch Med, Dept Urol, Nagasaki 8528501, Japan
Nishikido, M
Matsuya, F
论文数:
0
引用数:
0
h-index:
0
机构:
Nagasaki Univ, Sch Med, Dept Urol, Nagasaki 8528501, Japan
Nagasaki Univ, Sch Med, Dept Urol, Nagasaki 8528501, Japan
Matsuya, F
Kanetake, H
论文数:
0
引用数:
0
h-index:
0
机构:
Nagasaki Univ, Sch Med, Dept Urol, Nagasaki 8528501, Japan
Nagasaki Univ, Sch Med, Dept Urol, Nagasaki 8528501, Japan
Kanetake, H
Saito, Y
论文数:
0
引用数:
0
h-index:
0
机构:
Nagasaki Univ, Sch Med, Dept Urol, Nagasaki 8528501, Japan
Nagasaki Univ, Sch Med, Dept Urol, Nagasaki 8528501, Japan
Saito, Y
ANTICANCER RESEARCH,
1999,
19
(6C)
: 5547
-
5550
[10]
Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma (Reprinted from vol 27, pg 3584, 2009)
Motzer, Robert J.
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY USA
Motzer, Robert J.
Hutson, Thomas E.
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY USA
Hutson, Thomas E.
Tomczak, Piotr
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY USA
Tomczak, Piotr
Michaelson, M. Dror
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY USA
Michaelson, M. Dror
Bukowski, Ronald M.
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY USA
Bukowski, Ronald M.
Oudard, Stephane
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY USA
Oudard, Stephane
Negrier, Sylvie
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY USA
Negrier, Sylvie
Szczylik, Cezary
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY USA
Szczylik, Cezary
Pili, Roberto
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY USA
Pili, Roberto
Bjarnason, Georg A.
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY USA
Bjarnason, Georg A.
Garcia-del-Muro, Xavier
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY USA
Garcia-del-Muro, Xavier
Sosman, Jeffrey A.
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY USA
Sosman, Jeffrey A.
Solska, Ewa
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY USA
Solska, Ewa
Wilding, George
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY USA
Wilding, George
Thompson, John A.
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY USA
Thompson, John A.
Kim, Sindy T.
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY USA
Kim, Sindy T.
Chen, Isan
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY USA
Chen, Isan
Huang, Xin
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY USA
Huang, Xin
Figlin, Robert A.
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY USA
Figlin, Robert A.
JOURNAL OF CLINICAL ONCOLOGY,
2023,
41
(11)
: 1965
-
1971
←
1
2
3
4
5
→